日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Mesorhizobium sp. (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB (miaB) CSB-YP604782MAAK
CSB-EP604782MAAK
CSB-BP604782MAAK
CSB-MP604782MAAK
CSB-EP604782MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Putative thymidine phosphorylase (Meso_3880), partial CSB-YP604783MAAK
CSB-EP604783MAAK
CSB-BP604783MAAK
CSB-MP604783MAAK
CSB-EP604783MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Ribose 1,5-bisphosphate phosphokinase PhnN (phnN) CSB-YP604784MAAK
CSB-EP604784MAAK
CSB-BP604784MAAK
CSB-MP604784MAAK
CSB-EP604784MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Undecaprenyl-diphosphatase (uppP), partial CSB-YP604785MAAK1
CSB-EP604785MAAK1
CSB-BP604785MAAK1
CSB-MP604785MAAK1
CSB-EP604785MAAK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP604786MAAK
CSB-EP604786MAAK
CSB-BP604786MAAK
CSB-MP604786MAAK
CSB-EP604786MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. ATP-dependent protease subunit HslV (hslV) CSB-YP604787MAAK
CSB-EP604787MAAK
CSB-BP604787MAAK
CSB-MP604787MAAK
CSB-EP604787MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Shikimate dehydrogenase (aroE) CSB-YP604788MAAK
CSB-EP604788MAAK
CSB-BP604788MAAK
CSB-MP604788MAAK
CSB-EP604788MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. tRNA modification GTPase MnmE (mnmE) CSB-YP604789MAAK
CSB-EP604789MAAK
CSB-BP604789MAAK
CSB-MP604789MAAK
CSB-EP604789MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Glutamate 5-kinase (proB) CSB-YP604790MAAK
CSB-EP604790MAAK
CSB-BP604790MAAK
CSB-MP604790MAAK
CSB-EP604790MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. 50S ribosomal protein L19 (rplS) CSB-YP604791MAAK
CSB-EP604791MAAK
CSB-BP604791MAAK
CSB-MP604791MAAK
CSB-EP604791MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Phosphoglycerate kinase (pgk) CSB-YP604792MAAK
CSB-EP604792MAAK
CSB-BP604792MAAK
CSB-MP604792MAAK
CSB-EP604792MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Protease HtpX homolog (htpX), partial CSB-YP604793MAAK1
CSB-EP604793MAAK1
CSB-BP604793MAAK1
CSB-MP604793MAAK1
CSB-EP604793MAAK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. UPF0391 membrane protein Meso_3392 (Meso_3392), partial CSB-YP604794MAAK
CSB-EP604794MAAK
CSB-BP604794MAAK
CSB-MP604794MAAK
CSB-EP604794MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Argininosuccinate synthase (argG) CSB-YP604795MAAK
CSB-EP604795MAAK
CSB-BP604795MAAK
CSB-MP604795MAAK
CSB-EP604795MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. UPF0434 protein Meso_3270 (Meso_3270) CSB-YP604796MAAK
CSB-EP604796MAAK
CSB-BP604796MAAK
CSB-MP604796MAAK
CSB-EP604796MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. ATP synthase subunit beta (atpD), partial CSB-YP604797MAAK
CSB-EP604797MAAK
CSB-BP604797MAAK
CSB-MP604797MAAK
CSB-EP604797MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. ATP synthase subunit delta (atpH) CSB-YP604798MAAK
CSB-EP604798MAAK
CSB-BP604798MAAK
CSB-MP604798MAAK
CSB-EP604798MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP604799MAAK
CSB-EP604799MAAK
CSB-BP604799MAAK
CSB-MP604799MAAK
CSB-EP604799MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Phosphate import ATP-binding protein PstB (pstB) CSB-YP604800MAAK
CSB-EP604800MAAK
CSB-BP604800MAAK
CSB-MP604800MAAK
CSB-EP604800MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesorhizobium sp. Peptide chain release factor 1 (prfA) CSB-YP604801MAAK
CSB-EP604801MAAK
CSB-BP604801MAAK
CSB-MP604801MAAK
CSB-EP604801MAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×